Credit: Shutterstock. Study participants suffered from chronic back pain for an average of 12.8 years. The Food and Drug Administration (FDA) has expanded the approval of Abbott’s spinal cord ...
Dr. Martin Schreiber, Adjunct Professor of Surgery at Uniformed Service University and one of the nation's most influential trauma surgeons, was among the attending members at the 181st Meeting of the ...
Abbott Laboratories received U.S. FDA approval for an expanded indication for its spinal cord stimulator (SCS) devices to include treatment of chronic back pain for individuals who have not had or are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback